Department of Neurology
Nan Liu has not added Biography.
If you are Nan Liu and would like to personalize this page please email our Author Liaison for assistance.
Optimal Delay Time of CT Perfusion for Predicting Cerebral Parenchymal Hematoma After Intra-Arterial tPA Treatment.
Frontiers in neurology , 2018 | Pubmed ID: 30186221
Increased expression of EZH2 indicates aggressive potential of urothelial carcinoma of the bladder in a Chinese population.
Scientific reports Dec, 2018 | Pubmed ID: 30542123
Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway.
Medical science monitor : international medical journal of experimental and clinical research May, 2019 | Pubmed ID: 31042695
GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
OncoTargets and therapy , 2019 | Pubmed ID: 31571910
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study.
Cancer treatment and research communications , 2021 | Pubmed ID: 33848805
Circulating tumor DNA genomic profiling reveals the complicated olaparib-resistance mechanism in prostate cancer salvage therapy: A case report.
World journal of clinical cases Apr, 2022 | Pubmed ID: 35611209
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.
Cardiovascular research May, 2023 | Pubmed ID: 36464772
Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer.
British journal of cancer Mar, 2023 | Pubmed ID: 36681728
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer.
Cancer genetics Aug, 2023 | Pubmed ID: 37487324
Corrigendum to "Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer" [Cancer Genetics Volumes 276-277, August 2023, Pages 48-59].
Cancer genetics Nov, 2023 | Pubmed ID: 37734143
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models.
Translational oncology Jan, 2024 | Pubmed ID: 37897831
Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis.
Journal of advanced research Nov, 2024 | Pubmed ID: 39547438
Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume 39 (2024) 101803].
Translational oncology Feb, 2025 | Pubmed ID: 39848760
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.
Journal of translational medicine Feb, 2025 | Pubmed ID: 40012053
版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。